A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new ...

Scientists are designing mRNA vaccines to produce virus-like nanoparticles, which should lead to a more robust immune ...

A tiny molecule called a nanobody may succeed where today's cancer drugs often fail, according to University of Hawaiʻi at ...

In the fast-evolving field of medical science, a new artificial intelligence model may be about to change the way mRNA-based drugs and vaccines are designed. Developed through a collaboration between ...

Moderna, Inc. remains under pressure in 2025, despite recent next-gen COVID vaccine approval & cancer vaccine trial. Learn ...

New research has shown that nanobody treatments that block PD-L1 can reduce tumor growth by about 50% in cancers that don't ...

Clinical studies suggest these vaccines can generate immunological memory, allowing lymphocytes to respond to tumor ...

A research team led by Cancer Center at Illinois (CCIL) member Hua Wang has published new research detailing a new mRNA ...

CAR T therapy has been transformative in the battle against deadly cancers. Scientists extract a patient’s own immune cells, genetically engineer them to target a specific type of cancer, and infuse ...

But recently, scientists took inspiration for such a super drug from a quiet corner of the medical world: The small subset of ...

People are still debating whether the mRNA from COVID-19 vaccines remains in the body longer than it should. Some say it lingers and causes harm, others say that idea just doesn’t hold up. A new ...

The nano-sized messenger cells are hailed for their rejuvenating power—including signaling to the body when to make more ...